{"id":361979,"date":"2024-08-27T00:00:00","date_gmt":"2024-08-27T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcv0030-biopharma-acute-heart-failure-epidemiology-emerging-markets\/"},"modified":"2026-03-31T10:28:43","modified_gmt":"2026-03-31T10:28:43","slug":"epidcv0030-biopharma-acute-heart-failure-epidemiology-emerging-markets","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcv0030-biopharma-acute-heart-failure-epidemiology-emerging-markets\/","title":{"rendered":"Acute Heart Failure &#8211; Epidemiology &#8211; Emerging Markets"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of acute heart failure (<abbr title=\"acute heart failure\">AHF<\/abbr>) comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Brazil, China, India, Mexico, Russia, South Korea, and Turkey). We report the incidence of <abbr title=\"acute heart failure\">AHF<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Patient populations are forecast over a period of 10 years.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"acute heart failure\">AHF<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all people with <abbr title=\"acute heart failure\">AHF<\/abbr>, how many in each of the emerging pharmaceutical markets have been formally diagnosed?<\/li>\n<li>Of all people diagnosed with <abbr title=\"acute heart failure\">AHF<\/abbr>, how many in each of the emerging pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"acute heart failure\">AHF<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <span class=\"abbreviation-guard\">MS <\/span>Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology forecasts the following <abbr title=\"acute heart failure\">AHF<\/abbr> patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed events of <abbr title=\"acute heart failure\">AHF<\/abbr>.<\/li>\n<li>Diagnosed events of <abbr title=\"acute heart failure\">AHF<\/abbr> with reduced ejection fraction (<abbr title=\"heart failure with reduced ejection fraction\">HFrEF<\/abbr>).<\/li>\n<li>Diagnosed events of <abbr title=\"acute heart failure\">AHF<\/abbr> with preserved or mid-range ejection fraction (<abbr title=\"heart failure with preserved ejection fraction\">HFpEF<\/abbr> \/ <abbr title=\"heart failure with mid-range ejection fraction\">HFmrEF<\/abbr>).<\/li>\n<li>Diagnosed drug-treated events of <abbr title=\"acute heart failure\">AHF<\/abbr>.<\/li>\n<li>Diagnosed non-drug-treated events of <abbr title=\"acute heart failure\">AHF<\/abbr>.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-361979","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-acute-heart-failure","biopharma-therapy-areas-cardiovascular","biopharma-therapy-areas-heart-failure","biopharma-product-epidemiology","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/361979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/361979\/revisions"}],"predecessor-version":[{"id":362284,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/361979\/revisions\/362284"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=361979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}